Cargando…
Modifications of coagulation imbalance during antithrombin treatment in preeclamptic patients: our experience
Autores principales: | Buscemi, C, Pirri, S, Mangione, D, Giarratano, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4088584/ http://dx.doi.org/10.1186/cc6434 |
Ejemplares similares
-
Effects of antithrombin III (ATIII) treatment (high dose) in severe pre-eclampsia and HELLP syndrome with alterations of coagulation inhibitors and inflammatory markers: a preliminary report
por: Giarratano, A, et al.
Publicado: (2000) -
Antithrombin III concentrate may contribute to sepsis in nonovert disseminated intravascular coagulation
por: Saito, Noriko, et al.
Publicado: (2013) -
Relationship between protein C and antithrombin III deficiencies in sepsis without disseminated intravascular coagulation status
por: Takeda, Munekazu, et al.
Publicado: (2008) -
Cerebrovascular haemodynamics in preeclamptic patients
por: Shifman, E, et al.
Publicado: (2015) -
Role of thromboelastography in septic patients treated with coagulation inhibitor
por: Giarratano, A, et al.
Publicado: (2005)